John Paliakkara

John Paliakkara

Auto-generated profile, based on publicly available information

John Paliakkara

Department of Family Medicine; SUNY Upstate Medical University; Syracuse NY USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2025 in Psychiatry Research
Verified
Journal Article
Closed access
JPJohn Paliakkara
John Paliakkara
SEStacy Ellenberg
Stacy Ellenberg
AUAndrew Ursino
Andrew Ursino
ASAbigail Smith
Abigail Smith
JEJames Evans
James Evans
YZYanli Zhang-James
Yanli Zhang-James

13 September 2024 in medRxiv
Verified
Preprint
Open access
PDF file
YZYanli Zhang-James
Yanli Zhang-James
JPJohn Paliakkara
John Paliakkara
JSJoshua Schaeffer
Joshua Schaeffer
JSJoseph Strayhorn
Joseph Strayhorn
SFStephen V. V Faraone
Stephen V. V Faraone
Importance Intermittent Explosive Disorder (IED) is an understudied psychiatric condition that presents with repeated episodes of impulsive aggression and poorly regulated emotional control, often resulting in interpersonal and societal consequences. Better understanding of comor-bidities will allow for enhanced screening, diagnosis, and treatment of patients. Objective To investigate prevalence and associations of IED with psychiatric, neurological, and somatic disorders using real-world data Design Matched cohorts of patients with or without IED diagnosis were identified using data from the TriNetX Research Network (until January 31, 2024). Cox proportional hazard models were used to estimate and compare the probabilities of acquiring other diagnoses using pa-tients’ available medical records. Setting Analysis of electronic medical records from two patient populations. Participants 30,357 individuals with IED and equal number of demographically matched individuals without IED from the TriNetX Research. Exposure IED diagnosis identified through the associated ICD codes. Main Outcomes and Measures The main outcomes were ICD-10-CM diagnostic categories and root codes for disorders and health conditions in both cohorts. Main measures are total numbers and proportions of patients who had the diagnostic codes, as well as adjusted hazard ratios for IED diagnosis. Results Although only 0.03% of the total patient population had an IED diagnosis, we found extensive and widespread comorbidities with psychiatric, neurological and somatic conditions. A significant 95.7% of the individuals with IED had another psychiatric diagnosis. All psychiatric sub-categories and 95% of the psychiatric diagnoses were significantly associated with IED, with HRs ranging from 2 to 77. Among neurological conditions, neurodegenerative diseases and epilepsy had the highest HRs, followed by extrapyramidal and movement disorders, cerebral palsy and other paralytic syndromes, and sleep disorders. Notable associations with IED also includes conditions such as obesity, hyperlipidemia, hypertension, and GERD. Conclusion and Relevance Our findings illuminate the extensive comorbid relationships between IED and psychiatric, neurological, and somatic disorders. This underscores the necessity for an integrated diagnostic and treatment approach that addresses both the psychological and physical health aspects of IED. Additionally, our work highlights the need for more accurate and inclusive diagnosis of IED in patients with mental disorders. Key Points Focused Question: What is the pattern of comorbidity of IED with other disorders? Findings: Despite being underdiagnosed in the clinical cohort, IED was found significantly associated with a wide range of psychiatric disorders, many neurological, and some somatic disorders. Meaning: The widespread comorbidity highlights the critical need for integrated care approaches that consider the multifaceted health challenges faced by individuals with IED.

13 September 2024 in medRxiv
Verified
Preprint
Open access
PDF file
JPJohn Paliakkara
John Paliakkara
SEStacy Ellenberg
Stacy Ellenberg
AUAndrew Ursino
Andrew Ursino
ASAbigail Smith
Abigail Smith
JEJames Evans
James Evans
YZYanli Zhang-James
Yanli Zhang-James
Intermittent Explosive Disorder (IED) is characterized by repeated inability to control aggressive impulses. Although the etiology and neurobiology of impulsive anger and impulse control disorders have been reviewed, no systematic review on these aspects has been published for IED specifically. We conducted a systematic search in seven electronic databases for publications about IED, screened by two authors, and retained twenty-four studies for the review. Our findings highlight a multifactorial etiology and neurobiology of IED, emphasizing the role of the amygdala and orbitofrontal cortex in emotional regulation and impulse control, and supporting interventions that target serotonergic signaling. Research also shows that childhood trauma and adverse family environment may significantly contribute to the development of IED. Yet, genetic studies focusing on IED were largely lacking, despite many examining the genetics underlying aggression as a general trait or other related disorders. Future research using consistently defined IED as a phenotype is required to better understand the etiology and underlying mechanisms and assist in informing the development of more effective interventions for IED.

19 August 2025 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Open access
PDF file
SKSaehyeon Kim
Saehyeon Kim
JPJohn J Paliakkara
John J Paliakkara
JSJulia Schmutz
Julia Schmutz
NWNorio Watanabe
Norio Watanabe
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective is to examine the efficacy of botulinum toxin therapy in the treatment of provoked vestibulodynia (PVD) compared with placebo or no treatment. The secondary objectives are to investigate the dose effect of botulinum toxin and the complication rates associated with botulinum toxin.